IDH1 and astrocytoma (excluding glioblastoma): As higher-grade diffuse glioma tends to exhibit H3K27me3 expression, immunohistochemistry (IHC) for H3K27me3 could potentially predict the prognosis of astrocytoma, IDH-mutant.